Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/11/18 → 9/12/21 |
Funding
- ICON Clinical Research, LLC (EDP 305-101 // EDP 305-101)
- Enanta Pharmaceuticals, Inc. (EDP 305-101 // EDP 305-101)
Prot# EDP 305-101: A Phase 2 Dose Ranging, Randomized, Double Blind, and Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects with Non-alcoholic Steatohepatitis (NASH)
- Rinella, Mary Eugenia (PD/PI)
Project: Research project